Literature DB >> 19286843

Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.

Natallia M Akulevich1, Vladimir A Saenko, Tatiana I Rogounovitch, Valentina M Drozd, Eugeny F Lushnikov, Victor K Ivanov, Norisato Mitsutake, Ryo Kominami, Shunichi Yamashita.   

Abstract

Papillary thyroid carcinoma (PTC) etiologically occurs as a radiation-induced or sporadic malignancy. Genetic factors contributing to the susceptibility to either form remain unknown. In this retrospective case-control study, we evaluated possible associations between single-nucleotide polymorphisms (SNPs) in the candidate DNA damage response genes (ATM, XRCC1, TP53, XRCC3, MTF1) and risk of radiation-induced and sporadic PTC. A total of 255 PTC cases (123 Chernobyl radiation-induced and 132 sporadic, all in Caucasians) and 596 healthy controls (198 residents of Chernobyl areas and 398 subjects without history of radiation exposure, all Caucasians) were genotyped. The risk of PTC and SNPs interactions with radiation exposure were assessed by logistic regressions. The ATM G5557A and XRCC1 Arg399Gln polymorphisms, regardless of radiation exposure, associated with a decreased risk of PTC according to the multiplicative and dominant models of inheritance (odds ratio (OR) = 0.69, 95% confidence interval (CI) 0.45-0.86 and OR = 0.70, 95% CI 0.59-0.93 respectively). The ATM IVS22-77 T > C and TP53 Arg72Pro SNPs interacted with radiation (P = 0.04 and P = 0.01 respectively). ATM IVS22-77 associated with the increased risk of sporadic PTC (OR = 1.84, 95% CI 1.10-3.24) whereas TP53 Arg72Pro correlated with the higher risk of radiogenic PTC (OR = 1.80, 95% CI 1.06-2.36). In the analyses of ATM/TP53 (rs1801516/rs664677/rs609429/rs1042522) combinations, the GG/TC/CG/GC genotype strongly associated with radiation-induced PTC (OR = 2.10, 95% CI 1.17-3.78). The GG/CC/GG/GG genotype displayed a significantly increased risk for sporadic PTC (OR = 3.32, 95% CI 1.57-6.99). The results indicate that polymorphisms of DNA damage response genes may be potential risk modifiers of ionizing radiation-induced or sporadic PTCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286843     DOI: 10.1677/ERC-08-0336

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  38 in total

1.  Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.

Authors:  Fang Wang; Peng Wang; Bin Wang; Zheng-Ju Fu; Ying Yuan; Sheng-Li Yan; Wen-Juan Zhao; Yan-Gang Wang
Journal:  Tumour Biol       Date:  2013-12-28

2.  Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.

Authors:  Bo Wu; Dan Guo; Ying Guo
Journal:  Tumour Biol       Date:  2013-09-15

3.  Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.

Authors:  Gila Neta; Alina V Brenner; Erich M Sturgis; Ruth M Pfeiffer; Amy A Hutchinson; Briseis Aschebrook-Kilfoy; Meredith Yeager; Li Xu; William Wheeler; Michael Abend; Elaine Ron; Margaret A Tucker; Stephen J Chanock; Alice J Sigurdson
Journal:  Carcinogenesis       Date:  2011-06-03       Impact factor: 4.944

4.  Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.

Authors:  Jie Kang; Xian-Zhao Deng; You-Ben Fan; Bo Wu
Journal:  Tumour Biol       Date:  2014-04-24

5.  Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database.

Authors:  Kyriaki Antonopoulou; Irene Stefanaki; Christina M Lill; Foteini Chatzinasiou; Katerina P Kypreou; Fani Karagianni; Emmanouil Athanasiadis; George M Spyrou; John P A Ioannidis; Lars Bertram; Evangelos Evangelou; Alexander J Stratigos
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

6.  Association of Arg194Trp, Arg280His and Arg399Gln polymorphisms in X-ray repair cross-complementing group 1 gene and risk of differentiated thyroid carcinoma in Iran.

Authors:  Pezhman Fard-Esfahani; Armaghan Fard-Esfahani; Shima Fayaz; Bahareh Ghanbarzadeh; Parinaz Saidi; Reyhaneh Mohabati; Seyed Kazem Bidoki; Mina Majdi
Journal:  Iran Biomed J       Date:  2011

7.  Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.

Authors:  Lara E Sucheston-Campbell; Alyssa I Clay-Gilmour; William E Barlow; G Thomas Budd; Daniel O Stram; Christopher A Haiman; Xin Sheng; Li Yan; Gary Zirpoli; Song Yao; Chen Jiang; Kouros Owzar; Dawn Hershman; Kathy S Albain; Daniel F Hayes; Halle C Moore; Timothy J Hobday; James A Stewart; Abbas Rizvi; Claudine Isaacs; Muhammad Salim; Jule R Gralow; Gabriel N Hortobagyi; Robert B Livingston; Deanna L Kroetz; Christine B Ambrosone
Journal:  Pharmacogenet Genomics       Date:  2018-02       Impact factor: 2.089

8.  Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma.

Authors:  Li Xu; Elaine Cristina Morari; Qingyi Wei; Erich M Sturgis; Laura S Ward
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

Review 9.  Genetic predisposition for nonmedullary thyroid cancer.

Authors:  Rebecca Nagy; Matthew D Ringel
Journal:  Horm Cancer       Date:  2014-10-22       Impact factor: 3.869

10.  No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.

Authors:  Cuiping Li; Xue Xiang; Yang Zhou
Journal:  Mol Biol Rep       Date:  2014-08-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.